申请人:BEECHAM GROUP PLC
公开号:EP0042705A1
公开(公告)日:1981-12-30
Compounds of the formula (I) and pharmaceutically acceptable satls thereof:
wherein:
R1 is a C1-6 alkoxy or C1-6 alkylthio group;
R11 is hydrogen, amino or C1-7 acylamino;
R12 is C1-6 alkylsulphinyl;
R5 is hydrogen or C1-6 alkyl;
R6 is C1-7 alkyl or a group -(CH2)sR7 where s is 0 to 2 and R7 is a C3-8 cycloalkyl group, or a group -(CH2)tR8 where t is 1 or 2 and R8 is C2-5 alkenyl or a phenyl group optionally substituted by one or two substituents selected from Cl-6 alkyl, Cl-4 alkoxy, trifluoromethyl and halogen, or a thienyl group; and n, p and q are independently 0 to 2 having useful pharmacological activity, pharmaceutical compositions containing them and process for their preparation.
式 (I) 的化合物及其药学上可接受的饱和物:
其中
R1 是 C1-6 烷氧基或 C1-6 烷硫基;
R11 是氢、氨基或 C1-7 乙酰氨基
R12 是 C1-6 烷基亚磺酰基;
R5 是氢或 C1-6 烷基
R6 是 C1-7 烷基或基团-(CH2)sR7(其中 s 为 0 至 2,R7 为 C3-8 环烷基),或基团-(CH2)tR8(其中 t 为 1 或 2,R8 为 C2-5 烯基或苯基,可任选被选自 Cl-6 烷基、Cl-4 烷氧基、三氟甲基和卤素的一个或两个取代基取代,或被噻吩基取代);以及 n、p 和 q 独立地为 0 至 2,具有有用的药理活性,含有它们的药物组合物及其制备工艺。